Mutations in the sodium channel (SCN4A) gene are responsible for HyperPP, whereas mutations in two other genes lead to HypoPP, specifically SCN4A (HypoPP2) or the skeletal muscle calcium channel (CACNA1S) gene (HypoPP1) [2]. The gene discussed is SCN4A; the disease is hypokalemic periodic paralysis.